06.13.11
Bridgepoint Names CEO
Bridgepoint Medical Inc. has named former Boston Scientific Corp. sales executive Denis Harrington as its new president and CEO. He replaces Chad Kugler, who is now chief operating officer.
Harrington most recently was head of sales for Boston Scientific’s cardiovascular and cardiac rhythm management division.
Bridgepoint recently raised $9.1 million in venture capital, and is gearing up to market devices that treat patients with severe artery blockage. The startup company is based in Minneapolis, Minn.
Medrad Has New VP for Interventional Business
Jack Darby has joined Medrad Inc. as vice president of Medrad Interventional. Darby will act as general manager of both the diagnostic and therapeutic lines of the business on a global scale, and also will join the company’s executive leadership team.
"Jack's broad base of experience in the interventional space and combination drug-device products will complement our patient-focused goals for the interventional business," President and CEO Sam Liang said. "With the support of his leadership, we plan to extend our product innovation and customer satisfaction footprint within this growing, global market."
Medrad Interventional is a Bayer HealthCare company that operates out of Minneapolis, Minn., and Pittsburgh, Pa.
Bridgepoint Medical Inc. has named former Boston Scientific Corp. sales executive Denis Harrington as its new president and CEO. He replaces Chad Kugler, who is now chief operating officer.
Harrington most recently was head of sales for Boston Scientific’s cardiovascular and cardiac rhythm management division.
Bridgepoint recently raised $9.1 million in venture capital, and is gearing up to market devices that treat patients with severe artery blockage. The startup company is based in Minneapolis, Minn.
Medrad Has New VP for Interventional Business
Jack Darby has joined Medrad Inc. as vice president of Medrad Interventional. Darby will act as general manager of both the diagnostic and therapeutic lines of the business on a global scale, and also will join the company’s executive leadership team.
"Jack's broad base of experience in the interventional space and combination drug-device products will complement our patient-focused goals for the interventional business," President and CEO Sam Liang said. "With the support of his leadership, we plan to extend our product innovation and customer satisfaction footprint within this growing, global market."
Medrad Interventional is a Bayer HealthCare company that operates out of Minneapolis, Minn., and Pittsburgh, Pa.